Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
    Research/Science 5/11/2023

    At a glance
    In this general discussion post, the primary subjects mentioned are
    💧 KX-826 (topical) 0.5% 2x daily 24 weeks
    💧 Minoxidil (topical)
    💧 RU58841 (topical) 5% 1x daily 6 months
    💊 Dutasteride (oral)
    💊 oral Minoxidil (oral)
    the tone is 😐 neutral with some growth results.

    Other terms

    Kintor Pharma announced successful Phase II trial results for KX-826 in treating hair loss, showing it's comparable to finasteride and can be used with it. Some participants saw a 10 hair/cm^2 increase, which is considered a good outcome at the low dose used.
    View this post in the Community →

    Similar Community Posts Join

    5 / 182 results

    Related Research

    6 / 124 results